Viewing StudyNCT03054363



Ignite Creation Date: 2024-05-06 @ 9:43 AM
Last Modification Date: 2024-10-26 @ 12:18 PM
Study NCT ID: NCT03054363
Status: COMPLETED
Last Update Posted: 2023-11-13
First Post: 2017-02-07

Brief Title: Tucatinib Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer
Sponsor: University of Colorado Denver
Organization: University of Colorado Denver

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Ibrance View
Metastatic Breast Cancer View
Tucatinib View
Palbociclib View
Letrozole View
HR-positive View
HER2-positive View
ER-positive View
PR-positive View
HER2-targeted therapy View
CDK46 inhibitor View
ONT-380 View